Results 241 to 250 of about 95,782 (307)

Study on Weakening of Resistance of Isoniazid-Resistant Tubercle Bacilli, Catalase-Activity and Virulence

, 1963
Akira Nakatani
openalex   +2 more sources

Acute-phase proteins as biomarkers of inflammation in HIV patients with latent tuberculosis: a prospective study. [PDF]

Front Immunol
Pavan Kumar N, M R, Nancy A, Kumar BS, M J, Ahamed SF, Kumar V, S V, S S, R K, Baskaran D, Hissar S, Babu S.   +12 more
europepmc   +1 more source

History of clinical trials for the treatment of tuberculosis in China. Part 2: the advent and expansion of randomised controlled trials. [PDF]

J R Soc Med
Yu X, Chen Y, Podolsky SH.
europepmc   +1 more source

Cost effectiveness analysis of expanding tuberculosis preventive therapy to household contacts aged 5-14 years in the Philippines. [PDF]

J Clin Tuberc Other Mycobact Dis
Ilaiwy G, Keim-Malpass J, Tuppal R, Ritua AF, Bassiag FR, Thomas TA.   +5 more
europepmc   +1 more source

Abstract Supplement Abstracts from IAS 2025, the 13th IAS Conference on HIV Science, 13 – 17 July, Kigali, Rwanda & Virtual

Journal of the International AIDS Society, Volume 28, Issue S4, July 2025.
wiley   +1 more source

Completion of tuberculosis preventive treatment with 300 mg vs. 100 mg isoniazid tablets: a pragmatic randomized clinical trial. [PDF]

BMC Infect Dis
Cola JP, do Prado TN, Alves BMCS, Sales CMM, Borges BJP, Mascarello KC, Vieira ACBC, Rissino SDD, de Araújo WN, Tavares NUL, Maciel ELN.   +10 more
europepmc   +1 more source

Pharmacogenetic Study of Anti-TB Drugs in the Native Ancestry Peruvian Population. [PDF]

Pharmacol Res Perspect
Jaramillo-Valverde L, Horton MK, Poterico JA, Lanata CM, Guio H.   +4 more
europepmc   +1 more source

Nanopore-based targeted sequencing (NTS) for drug-resistant tuberculosis: an integrated tool for personalized treatment strategies and guidance for new drug development. [PDF]

BMC Infect Dis
Yang C, Dai G, Guo Y, Wang T, Gao W, Zeng Y.   +5 more
europepmc   +1 more source

Tuberculosis among young contacts of patients with multidrug-resistant pulmonary tuberculosis in a reference hospital. [PDF]

J Pediatr (Rio J)
Rubin EF, Lucena SC, Bhering M, Gonçalves L, Falcão F, Dalcolmo M, Migliori GB, Saderi L, Sotgiu G, Kritski A, Carvalho ACC.   +10 more
europepmc   +1 more source

Development and validation of BCG vaccine-induced novel granulomatous liver injury preclinical animal model. [PDF]

Animal Model Exp Med
Sharma S, Moudgil A, Grewal J, Khatri P, Sharma V, Premkumar M, Bal A, Banerjee D, Patil AN.   +8 more
europepmc   +1 more source